Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.

Jovanović B, Sheng Q, Seitz RS, Lawrence KD, Morris SW, Thomas LR, Hout DR, Schweitzer BL, Guo Y, Pietenpol JA, Lehmann BD.

BMC Cancer. 2017 Apr 4;17(1):241. doi: 10.1186/s12885-017-3237-1.

2.

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.

Ring BZ, Hout DR, Morris SW, Lawrence K, Schweitzer BL, Bailey DB, Lehmann BD, Pietenpol JA, Seitz RS.

BMC Cancer. 2016 Apr 18;16:275. doi: 10.1186/s12885-016-2307-0. No abstract available.

3.

Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion-positive lung cancer patient.

Weber B, Liu M, Sobkin P, Morris SW, Hout D, van der Westhuizen N, Tonseth RP, Saltman DL.

J Med Radiat Sci. 2016 Mar;63(1):67-70. doi: 10.1002/jmrs.144. Epub 2015 Oct 3.

4.

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.

Ring BZ, Hout DR, Morris SW, Lawrence K, Schweitzer BL, Bailey DB, Lehmann BD, Pietenpol JA, Seitz RS.

BMC Cancer. 2016 Feb 23;16:143. doi: 10.1186/s12885-016-2198-0. Erratum in: BMC Cancer. 2016;16(1):275.

5.

Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients.

Wang X, Ring BZ, Seitz RS, Ross DT, Woolf K, Beck RA, Hicks DG, Yeh S.

BMC Clin Pathol. 2015 Dec 9;15:21. doi: 10.1186/s12907-015-0021-5. eCollection 2015.

6.

Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease.

Lawrence K, Berry B, Handshoe J, Hout D, Mazzola R, Morris SW, Saltman DL.

BMC Res Notes. 2015 Jul 18;8:308. doi: 10.1186/s13104-015-1277-7.

7.

Personalized medicine for pathological circadian dysfunctions.

Skelton RL, Kornhauser JM, Tate BA.

Front Pharmacol. 2015 Jun 19;6:125. doi: 10.3389/fphar.2015.00125. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center